Petri N, Borgå O, Nyberg L, Hedeland M, Bondesson U, Lennernäs H: Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. Int J Clin Pharmacol Ther 2006;44:71-79.

Nyberg L, Månsson W, Abrahamsson B, Seidegård J, Borgå O. A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: Experiences from thirteen phase I studies. Eur J Pharmaceut Sci 2007;30:432-440.

Seidegård J, Nyberg L, Borgå O. Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole. Eur J Pharmaceut Sci 2008;35:264-270.


Seidegård J, Nyberg L, Borgå O. Differentiating mucosal and hepatic metabolism of budesonide by local pretreatment with increasing doses of ketoconazole in the proximal jejunum. Eur J Pharmaceut Sci 2012; 46: 530-536


Dahlgren D, Roos C, Lundqvist A, Abrahamsson B, Tannergren C, Hellström PM, Sjögren E, Lennernäs H. Regional intestinal permeability of three model drugs in human. Mol Pharmaceutics 2016; 13: 3013-3021


Hofmann M, Thieringer F, Nguyen MA, Månsson W, Galle PR, Langguth P. A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations. Eur J Pharm Biopharm 2019; 136: 192-202


Hofmann M, Garcia MA, Al-Gousous J, Ruiz-Pcazo A, Thieringer F, Nguyen MA, Månsson W, Galle PR, Langguth P. In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions. Eur J Pharm Biopharm In press